))
Tail Risks 2021
Manage episode 403072083 series 3234084
Innhold levert av OCBC Treasury Research and Strategy - Podcast, OCBC Treasury Research, and Strategy - Podcast. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av OCBC Treasury Research and Strategy - Podcast, OCBC Treasury Research, and Strategy - Podcast eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
Vaccine haves and have-nots. Stepping into 2021, let’s take a look at the potential tail risks presented by vaccine development. On the positive end, if we can find more “sweet spot” vaccines that are not just effective but relatively easy to roll out in many developing countries, we would see a great upsurge in consumer and business confidence. On the flip side, if such vaccines are not readily available, a sharp dichotomy between the (vaccinated) rich world and (unvaccinated) others could have tremendous negative implications on market sentiment towards emerging markets in 2021.
…
continue reading
136 episoder
Del
